It Takes Two: Combining Biologics and Injectable Weight Loss Drugs to Boost Outcomes in PsO, Other Inflammatory Diseases
Injectable weight loss medications such as tirzepatide and semaglutide have helped millions of Americans shed excess weight. Now, researchers are looking at pairing these glucagon-like peptide 1 (GLP–1) agonistsand dual GLP-1/ glucose-dependent insulinotropic polypeptide (GIP) receptor agonists with drugs that treat inflammatory diseases such as psoriasis to see if the combination boosts effectiveness. TDD talked […]